Phase 1 safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial

Intensive Care Med. 2018 Nov;44(11):2006-2008. doi: 10.1007/s00134-018-5374-7. Epub 2018 Sep 25.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Critical Illness
  • Female
  • Humans
  • Hypoglycemic Agents / pharmacokinetics*
  • Male
  • Pioglitazone / pharmacokinetics*
  • Sepsis / metabolism
  • Sepsis / therapy*

Substances

  • Hypoglycemic Agents
  • Pioglitazone

Associated data

  • ClinicalTrials.gov/NCT01352182